1. Home
  2. WING vs ALKS Comparison

WING vs ALKS Comparison

Compare WING & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wingstop Inc.

WING

Wingstop Inc.

HOLD

Current Price

$246.33

Market Cap

6.7B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$29.55

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WING
ALKS
Founded
1994
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.5B
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
WING
ALKS
Price
$246.33
$29.55
Analyst Decision
Strong Buy
Buy
Analyst Count
26
14
Target Price
$339.88
$43.43
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
05-22-2026
05-22-2026
Dividend Yield
0.50%
N/A
EPS Growth
67.84
N/A
EPS
6.21
1.43
Revenue
$696,853,000.00
$1,475,899,000.00
Revenue This Year
$19.88
$24.94
Revenue Next Year
$16.90
$3.47
P/E Ratio
$38.31
$21.13
Revenue Growth
11.35
N/A
52 Week Low
$204.09
$25.17
52 Week High
$388.14
$36.32

Technical Indicators

Market Signals
Indicator
WING
ALKS
Relative Strength Index (RSI) 46.34 34.13
Support Level $227.67 $29.20
Resistance Level $276.53 $31.69
Average True Range (ATR) 18.07 1.14
MACD -0.76 -0.53
Stochastic Oscillator 33.71 4.80

Price Performance

Historical Comparison
WING
ALKS

About WING Wingstop Inc.

Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, expanding to 2,932 global stores at the end of the third quarter of 2025. With a 98% franchised model, Wingstop generates the lion's share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: